Another possibility is that by deleting Ng2/Cspg4 at tumor initiation, we are changing the cell type that becomes the tumor or changing the type of tumor that develops; however, in our analysis to date, we have not found differences between the sarcomas to suggest a difference in tumor cell type. This evidence concerns the gene CSPG4 and sarcoma.